EyePoint Pharmaceuticals, Inc. financial data

Symbol
EYPT on Nasdaq
Location
480 Pleasant Street, Suite B300, Watertown, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 774 % +49.4%
Quick Ratio 5.99 % -3.23%
Debt-to-equity 23.4 % -35%
Return On Equity -76.1 % -77%
Return On Assets -61.7 % -95.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 82.8M shares +21.3%
Common Stock, Shares, Outstanding 69.6M shares +30%
Entity Public Float 451M USD +93.6%
Common Stock, Value, Issued 70K USD +32.1%
Weighted Average Number of Shares Outstanding, Basic 70.2K shares
Weighted Average Number of Shares Outstanding, Diluted 70.2K shares

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 42.3M USD -7.38%
Research and Development Expense 205M USD +91%
Selling and Marketing Expense -5.85M USD -193%
General and Administrative Expense 52.8M USD +3.32%
Costs and Expenses 43.3M USD +46.2%
Operating Income (Loss) -218M USD -86.7%
Nonoperating Income (Expense) 12.8M USD -5.36%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -59.7M USD -103%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -206M USD -98.7%
Earnings Per Share, Basic -3 USD/shares -50.8%
Earnings Per Share, Diluted -3 USD/shares -50.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 74.6M USD -6.58%
Marketable Securities, Current 129M USD -25.6%
Cash, Cash Equivalents, and Short-term Investments 204M USD -19.6%
Inventory, Net 2.11M USD -24.8%
Other Assets, Current 899K USD -30.7%
Assets, Current 216M USD -19.5%
Property, Plant and Equipment, Net 8.86M USD +5.6%
Operating Lease, Right-of-Use Asset 20.7M USD -3.48%
Other Assets, Noncurrent 5.92M USD +144%
Assets 252M USD -16.4%
Accounts Payable, Current 10.1M USD +37.2%
Employee-related Liabilities, Current 10.9M USD +22.7%
Accrued Liabilities, Current 17.9M USD +26.7%
Liabilities, Current 30.1M USD -38.3%
Operating Lease, Liability, Noncurrent 21.3M USD -2.83%
Other Liabilities, Noncurrent 118K USD -49.4%
Liabilities 51.5M USD -37.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 919K USD -21.5%
Retained Earnings (Accumulated Deficit) -1.04B USD -24.7%
Stockholders' Equity Attributable to Parent 200M USD -8.48%
Liabilities and Equity 252M USD -16.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -53.1M USD -70.4%
Net Cash Provided by (Used in) Financing Activities -951K USD -927%
Net Cash Provided by (Used in) Investing Activities 39.5M USD +90%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 69.6M shares +30%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.5M USD -41.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 74.7M USD -6.57%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 185M USD +26.6%
Deferred Tax Assets, Gross 191M USD +29.3%
Operating Lease, Liability 23.3M USD +0.66%
Depreciation 497K USD +64%
Payments to Acquire Property, Plant, and Equipment 276K USD -76.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -206M USD -99.5%
Lessee, Operating Lease, Liability, to be Paid 45.5M USD -4.72%
Property, Plant and Equipment, Gross 12.2M USD +56.4%
Operating Lease, Liability, Current 1.96M USD +65.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.58M USD +10.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.48M USD +25%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 22.2M USD -9.77%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.47M USD -17.8%
Deferred Tax Assets, Operating Loss Carryforwards 103M USD +24.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.67M USD -19.6%
Operating Lease, Payments 600K USD
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 0 USD -100%
Share-based Payment Arrangement, Expense 29.6M USD +3.43%
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%